4 Merger and Acquisitions Stock Stories Causing a Monday Buzz

Lowe’s Companies (NYSE:LOW): Current price $41.24

The home-improvement giant will pay $205 million to buy a minimum of 60 Orchard Supply Hardware stores in California following the latter filing for bankruptcy relief. The purchase will provide Lowe’s with a smaller store format and also allow it access to a new customer base in California, in which it already operates 110 outlets, according to a Monday statement. Along with the cash purchase price, Lowe’s will assume amounts owed to close to all of Orchard’s vendors. Lowe’s said that it is attempting to grow its number of stores in the state as housing recovers.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

low

BioScrip (NASDAQ: BIOS): Current price $15.80

On Monday, BioScrip said it will acquire the business of CarePoint Partners Holdings, together with its subsidiaries, at a cash price of $223 million, subject to some adjustments. CarePoint Partners is a top national supplier of home and alternate-site infusion therapy for patients suffering from complex, acute and chronic illnesses. The buyer also expects to obtain the value of a future tax benefit calculated at $45 million, resulting from the transaction, yielding a net purchase price of $178 million. The transaction is set to close in the third quarter.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

bios

IntercontinentalExchange (NYSE:ICE): Current price $178.70

ICE is poised to win unconditional European Union clearance for its $8.2-billion offer for NYSE Euronext (NYSE:NYX), following antitrust regulators seeing no competition worries, according to two inside sources on Monday. The purchase will allow ICE control of Liffe, which is the number-two derivatives market on the Continent, and also reinforce its presence in the interest rate futures business. One sources commented that “the deal is expected to be approved by the European Commission without any conditions.”

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

ice

Teva Pharmaceutical Industries (NYSE: TEVA): Current price $39.18

Teva said Monday announced that it will acquire the privately-held MicroDose Therapeutx, which is a pharmaceutical and drug delivery firm that concentrates upon inhalation technologies and products for lung diseases and infections, possessing the potential to dramatically improve efficacy and patient compliance. With the acquisition of MicroDoses tech and products, Teva is moving towards expanding its respiratory pipeline; the buyer will now have access to MicroDoses proprietary tech, including its multi-dose dry powder nebulizer device, which needs no preparation and can be administered in fewer than 30 seconds.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

teva

Don’t Miss: Manufacturing Outlook Worsens Despite June Recovery.